261 related articles for article (PubMed ID: 25405290)
1. Identification of natural compound carnosol as a novel TRPA1 receptor agonist.
Zhai C; Liu Q; Zhang Y; Wang S; Zhang Y; Li S; Qiao Y
Molecules; 2014 Nov; 19(11):18733-46. PubMed ID: 25405290
[TBL] [Abstract][Full Text] [Related]
2. Human TRPM8 and TRPA1 pain channels, including a gene variant with increased sensitivity to agonists (TRPA1 R797T), exhibit differential regulation by SRC-tyrosine kinase inhibitor.
Morgan K; Sadofsky LR; Crow C; Morice AH
Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 24975826
[TBL] [Abstract][Full Text] [Related]
3. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular determinants for a potent mammalian TRPA1 antagonist by utilizing species differences.
Nakatsuka K; Gupta R; Saito S; Banzawa N; Takahashi K; Tominaga M; Ohta T
J Mol Neurosci; 2013 Nov; 51(3):754-62. PubMed ID: 23872983
[TBL] [Abstract][Full Text] [Related]
5. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis determining inhibition/activation of nociceptive receptor TRPA1 protein: a single amino acid dictates species-specific actions of the most potent mammalian TRPA1 antagonist.
Banzawa N; Saito S; Imagawa T; Kashio M; Takahashi K; Tominaga M; Ohta T
J Biol Chem; 2014 Nov; 289(46):31927-31939. PubMed ID: 25271161
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Nakao S; Mabuchi M; Wang S; Kogure Y; Shimizu T; Noguchi K; Tanaka A; Dai Y
Bioorg Med Chem Lett; 2017 Jul; 27(14):3167-3172. PubMed ID: 28576617
[TBL] [Abstract][Full Text] [Related]
8. Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels.
Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
Pain; 2011 May; 152(5):1156-1164. PubMed ID: 21353389
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of human TRPA1 channels by clinical concentrations of the antirheumatic drug auranofin.
Hatano N; Suzuki H; Muraki Y; Muraki K
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C354-61. PubMed ID: 23220116
[TBL] [Abstract][Full Text] [Related]
10. Activation of transient receptor potential ankyrin-1 (TRPA1) in lung cells by wood smoke particulate material.
Shapiro D; Deering-Rice CE; Romero EG; Hughen RW; Light AR; Veranth JM; Reilly CA
Chem Res Toxicol; 2013 May; 26(5):750-8. PubMed ID: 23541125
[TBL] [Abstract][Full Text] [Related]
11. Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels.
Oguri G; Nakajima T; Yamamoto Y; Takano N; Tanaka T; Kikuchi H; Morita T; Nakamura F; Yamasoba T; Komuro I
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(9):H1339-52. PubMed ID: 25172898
[TBL] [Abstract][Full Text] [Related]
12. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
[TBL] [Abstract][Full Text] [Related]
13. Oxidized Phospholipid OxPAPC Activates TRPA1 and Contributes to Chronic Inflammatory Pain in Mice.
Liu B; Tai Y; Caceres AI; Achanta S; Balakrishna S; Shao X; Fang J; Jordt SE
PLoS One; 2016; 11(11):e0165200. PubMed ID: 27812120
[TBL] [Abstract][Full Text] [Related]
14. The NADPH oxidase inhibitor diphenyleneiodonium activates the human TRPA1 nociceptor.
Suzuki H; Hatano N; Muraki Y; Itoh Y; Kimura S; Hayashi H; Onozaki K; Ohi Y; Haji A; Muraki K
Am J Physiol Cell Physiol; 2014 Aug; 307(4):C384-94. PubMed ID: 24944203
[TBL] [Abstract][Full Text] [Related]
15. TRPA1.
García-Añoveros J; Nagata K
Handb Exp Pharmacol; 2007; (179):347-62. PubMed ID: 17217068
[TBL] [Abstract][Full Text] [Related]
16. A Potent and Site-Selective Agonist of TRPA1.
Takaya J; Mio K; Shiraishi T; Kurokawa T; Otsuka S; Mori Y; Uesugi M
J Am Chem Soc; 2015 Dec; 137(50):15859-64. PubMed ID: 26630251
[TBL] [Abstract][Full Text] [Related]
17. TRPA1 antagonists as potential analgesic drugs.
Andrade EL; Meotti FC; Calixto JB
Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
[TBL] [Abstract][Full Text] [Related]
18. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.
Koivisto A; Hukkanen M; Saarnilehto M; Chapman H; Kuokkanen K; Wei H; Viisanen H; Akerman KE; Lindstedt K; Pertovaara A
Pharmacol Res; 2012 Jan; 65(1):149-58. PubMed ID: 22133672
[TBL] [Abstract][Full Text] [Related]
20. Activation of transient receptor potential ankyrin 1 by quercetin and its analogs.
Nakamura T; Miyoshi N; Ishii T; Nishikawa M; Ikushiro S; Watanabe T
Biosci Biotechnol Biochem; 2016 May; 80(5):949-54. PubMed ID: 26806540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
